
Bristol-Myers Positive, Cooper Jumps, WBD Declines
Bristol-Myers (BMY) Analysts are citing a positive readacross to Bristol-Myers from positive results for Bayer's experimental stroke-prevention drug Cantor: Bayer’s data supports confidence in BMY’s own program in secondary stroke prevention Earlier this month: shares fell after one of its most important experimental medicines appeared unlikely to benefit patients who had suffered a heart complication, another setback for the drugmaker’s product pipeline Cooper (COO) Maker of medical devices and surgical instruments; Activist investors Browning West wrote a letter to the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.